Literature DB >> 19194656

Cathepsin X-mediated beta2 integrin activation results in nanotube outgrowth.

N Obermajer1, Z Jevnikar, B Doljak, A M Sadaghiani, M Bogyo, J Kos.   

Abstract

Membrane nanotubes were recently described as a new principle of cell-cell communication enabling complex and specific messaging to distant cells. Calcium fluxes, vesicles, and cell-surface components can all traffic between cells connected by nanotubes. Here we report for the first time the mechanism of membrane nanotube formation in T cells through LFA-1 (CD11a/CD18; alpha(L)beta(2)) integrin activation by the cysteine protease cathepsin X. Cathepsin X is shown to induce persistent LFA-1 activation. Cathepsin X-upregulated T cells exhibit increased homotypic aggregation and polarized, migration-associated morphology in 2D and 3D models, respectively. In these cells, extended uropods are frequently formed, which subsequently elongate to nanotubes connecting T lymphocytes. Our results demonstrate that LFA-1 activation with subsequent cytoskeletal reorganization induces signal transmission through a physically connected network of T lymphocytes for better coordination of their action at various stages of the immune response.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19194656     DOI: 10.1007/s00018-009-8829-8

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  11 in total

Review 1.  Mechanisms and functions for the duration of intercellular contacts made by lymphocytes.

Authors:  Daniel M Davis
Journal:  Nat Rev Immunol       Date:  2009-07-17       Impact factor: 53.106

Review 2.  Intercellular nanotubes: insights from imaging studies and beyond.

Authors:  Johan Hurtig; Daniel T Chiu; Björn Onfelt
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2010 May-Jun

3.  The growth determinants and transport properties of tunneling nanotube networks between B lymphocytes.

Authors:  Anikó Osteikoetxea-Molnár; Edina Szabó-Meleg; Eszter Angéla Tóth; Ádám Oszvald; Emese Izsépi; Mariann Kremlitzka; Beáta Biri; László Nyitray; Tamás Bozó; Péter Németh; Miklós Kellermayer; Miklós Nyitrai; Janos Matko
Journal:  Cell Mol Life Sci       Date:  2016-04-28       Impact factor: 9.261

4.  Radial sizing of lipid nanotubes using membrane displacement analysis.

Authors:  Natalia Stepanyants; Gavin D M Jeffries; Owe Orwar; Aldo Jesorka
Journal:  Nano Lett       Date:  2012-02-24       Impact factor: 11.189

Review 5.  Cysteine Cathepsins in Tumor-Associated Immune Cells.

Authors:  Tanja Jakoš; Anja Pišlar; Anahid Jewett; Janko Kos
Journal:  Front Immunol       Date:  2019-08-28       Impact factor: 7.561

6.  Cathepsin X in serum from patients with colorectal cancer: relation to prognosis.

Authors:  Tjasa Vizin; Ib Jarle Christensen; Hans Jørgen Nielsen; Janko Kos
Journal:  Radiol Oncol       Date:  2012-07-24       Impact factor: 2.991

7.  Induction of premalignant host responses by cathepsin x/z-deficiency in Helicobacter pylori-infected mice.

Authors:  Sabine Krueger; Anja Bernhardt; Thomas Kalinski; Martin Baldensperger; Michael Zeh; Anne Teller; Daniela Adolf; Thomas Reinheckel; Albert Roessner; Doerthe Kuester
Journal:  PLoS One       Date:  2013-07-30       Impact factor: 3.240

8.  Prognostic and predictive value of cathepsin X in serum from colorectal cancer patients.

Authors:  Tjaša Vižin; Ib Jarle Christensen; Michael Wilhelmsen; Hans Jørgen Nielsen; Janko Kos
Journal:  BMC Cancer       Date:  2014-04-13       Impact factor: 4.430

9.  [Clinical significance of detection of cathepsin X and cystatin C in the sera of patients with lung cancer].

Authors:  Xuede Zhang; Yanli Hou; Zequn Niu; Wei Li; Xia Meng; Na Zhang; Shuanying Yang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2013-08-20

10.  Cathepsin X Activity Does Not Affect NK-Target Cell Synapse but Is Rather Distributed to Cytotoxic Granules.

Authors:  Tanja Jakoš; Mateja Prunk; Anja Pišlar; Janko Kos
Journal:  Int J Mol Sci       Date:  2021-12-16       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.